SG Americas Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

SG Americas Securities’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Sell	19,700 -14,300	-42%	-$455K	﹤0.01%	2768
2026 Q1	$76K	Sell	34,000 -20,000	-37%	-$586K	﹤0.01%	2982
2025 Q4	$215K	Buy	54,000 +20,000	+59%	+$600K	﹤0.01%	2898
2025 Q3	$170K	Hold	34,000	–	–	﹤0.01%	2824
2025 Q2	$146K	Hold	34,000	–	–	﹤0.01%	2439
2025 Q1	$100K	Hold	34,000	–	–	﹤0.01%	3054
2024 Q4	$160K	Buy	+34,000	New	+$837K	﹤0.01%	2353

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SG Americas Securities's ARKG Position: Q2 2026 in Review

SG Americas Securities increased its ARK Genomic Revolution ETF (ARKG) stake by 1,294% in Q2 2026, buying an estimated $6.5M and bringing the position to 220,010 shares worth $9.25M. The position accounts for 0.01% of the portfolio, ranked #860.

SG Americas Securities first reported a position in ARKG in Q1 2019 and has held it in 24 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

SG Americas Securities held 220,010 shares of ARK Genomic Revolution ETF worth $9.25M as of Q2 2026.
SG Americas Securities bought 204,224 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $6.5M.
ARK Genomic Revolution ETF made up 0.01% of SG Americas Securities's portfolio in Q2 2026, its #860 holding.
SG Americas Securities first reported a position in ARK Genomic Revolution ETF in Q1 2019 and has held it in 24 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.